BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9066701)

  • 21. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2002; 16(6):583-8. PubMed ID: 12494904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [p53 antioncogene abnormal in osteosarcoma].
    Guo W; Wang SW; Feng CH
    Zhonghua Wai Ke Za Zhi; 1994 Jul; 32(7):412-5. PubMed ID: 7842979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical analysis of heat shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix.
    Park CS; Joo IS; Song SY; Kim DS; Bae DS; Lee JH
    Gynecol Oncol; 1999 Jul; 74(1):53-60. PubMed ID: 10385551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs.
    Gamblin RM; Sagartz JE; Couto CG
    Am J Vet Res; 1997 Aug; 58(8):857-63. PubMed ID: 9256970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical study of p53 in human lung carcinomas.
    Brambilla E; Gazzeri S; Moro D; Caron de Fromentel C; Gouyer V; Jacrot M; Brambilla C
    Am J Pathol; 1993 Jul; 143(1):199-210. PubMed ID: 8317547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats.
    Stefanou DG; Nonni AV; Kalpouzos G; Evangelou A; Agnantis NJ
    In Vivo; 1998; 12(5):511-21. PubMed ID: 9827359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.
    Bártek J; Bártková J; Lukás J; Stasková Z; Vojtĕsek B; Lane DP
    J Pathol; 1993 Jan; 169(1):27-34. PubMed ID: 8433213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
    Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Lukás J; Rejthar A; Kovarík J; Midgley CA; Gannon JV; Lane DP
    Oncogene; 1991 Sep; 6(9):1699-703. PubMed ID: 1923535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCL-2 and P53 expression in endometrial carcinoma.
    Erkanli S; Eren F; Pekin S; Bagis T
    J Exp Clin Cancer Res; 2004 Mar; 23(1):97-103. PubMed ID: 15149157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
    de Oliveira LR; Ribeiro-Silva A; Zucoloto S
    J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P53 overexpression in normal oral mucosa of heavy smokers.
    Ayan N; Ayan I; Alatli C; Guler SD; Dalkilic C; Cinar F; Dogan O
    J Exp Clin Cancer Res; 2000 Dec; 19(4):525-9. PubMed ID: 11277333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational analysis of p53 in human tumors: immunocytochemistry.
    Slade N; Moll UM
    Methods Mol Biol; 2003; 234():231-43. PubMed ID: 12824536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid.
    van den Berg FM; Baas IO; Polak MM; Offerhaus GJ
    Am J Pathol; 1993 Feb; 142(2):381-5. PubMed ID: 8434637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
    Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of p53 and c-erbB2 proteins in breast cancer in Egypt.
    el-A Helal T; Khalifa A; Kamel AS
    Anticancer Res; 2000; 20(3B):2145-50. PubMed ID: 10928168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.